Follicular Fluid Anti-Mullerian Hormone (AMH) levels and Assisted Reproductive Technology (ART) outcomes.
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: N979- Female infertility, unspecified
- Registration Number
- CTRI/2019/05/019433
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Women between 23-40 years of age undergoing ART includes In vitro insemination (IVI) and intracytoplasmic sperm injection (ICSI)
Exclusion Criteria
Diminished ovarian reserve-defined as Serum AMH levels <1.1ng/dl or less than 4 follicles measuring 17mm each on day of trigger
Stage III-IV endometriosis
Intracytoplasmic sperm injection done using surgically retrieved spermatozoa
Cycles where no oocytes retrieved on the day of aspiration.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method